PortfoliosLab logo

Aytu BioPharma, Inc. (AYTU)

Equity · Currency in USD · Last updated Sep 17, 2022

Company Info

ISINUS0547548745
CUSIP054754874
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Trading Data

Previous Close$0.21
Year Range$0.21 - $3.12
EMA (50)$0.36
EMA (200)$1.06
Average Volume$1.30M
Market Capitalization$13.05M

AYTUShare Price Chart


Chart placeholderClick Calculate to get results

AYTUPerformance

The chart shows the growth of $10,000 invested in Aytu BioPharma, Inc. in Mar 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $0 for a total return of roughly -100.00%. All prices are adjusted for splits and dividends.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%AprilMayJuneJulyAugustSeptember
-100.00%
-13.18%
AYTU (Aytu BioPharma, Inc.)
Benchmark (^GSPC)

AYTUReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-25.36%-10.03%
6M-81.00%-12.20%
YTD-84.52%-18.73%
1Y-93.13%-13.56%
5Y-80.91%9.16%
10Y-87.11%10.89%

AYTUMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-2.96%-3.82%-14.29%-40.74%-14.06%25.45%-24.64%-57.69%-5.00%
202119.40%7.42%-0.91%-12.89%-23.26%-1.38%-20.76%-4.28%-24.21%-13.54%-21.29%-31.12%
2020-25.66%-26.69%183.02%9.33%-9.15%-4.70%-2.11%-23.74%12.26%-20.14%-7.00%-32.34%
201948.91%-0.85%42.74%22.75%-21.46%17.39%-17.46%-10.59%-13.25%-14.88%-18.56%15.94%
201830.49%-77.98%-0.61%-27.00%-26.67%-23.05%30.91%-37.26%-35.96%-61.59%-4.72%-21.54%
2017-14.17%-9.13%-3.90%-16.62%-13.33%-9.23%-1.69%-67.67%6.67%-17.60%-13.83%-21.48%
2016-74.67%-33.68%0.79%-33.70%-4.99%-3.75%-15.58%-3.85%-13.07%-57.06%-15.00%0.84%
201531.58%0.00%-20.00%100.00%2.50%-7.32%0.00%2.68%0.00%-5.26%-26.67%13.64%
20140.00%0.00%42.86%2.00%-43.14%-30.69%0.00%-17.91%15.15%0.00%0.00%0.00%
20130.00%0.00%-14.29%-41.83%-14.04%-16.67%-20.00%0.00%0.00%75.00%0.00%0.00%
20120.00%120.00%-74.03%250.00%-71.43%250.00%0.00%0.00%0.00%0.00%0.00%0.00%
201156.25%0.00%104.00%-41.18%-16.67%0.00%12.00%0.00%0.00%25.00%0.00%0.00%
2010-23.47%0.00%0.00%-73.33%70.00%-0.00%0.00%17.65%0.00%-20.00%

AYTUSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aytu BioPharma, Inc. Sharpe ratio is -1.00. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.50-1.00-0.500.000.501.00AprilMayJuneJulyAugustSeptember
-1.00
-0.62
AYTU (Aytu BioPharma, Inc.)
Benchmark (^GSPC)

AYTUDividend History


Aytu BioPharma, Inc. doesn't pay dividends

AYTUDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugustSeptember
-100.00%
-19.25%
AYTU (Aytu BioPharma, Inc.)
Benchmark (^GSPC)

AYTUWorst Drawdowns

The table below shows the maximum drawdowns of the Aytu BioPharma, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aytu BioPharma, Inc. is 100.00%, recorded on Sep 16, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-100%Apr 27, 20151716Sep 16, 2022
-81.63%Mar 16, 20107Jul 20, 201013Mar 10, 201120
-78.57%Mar 7, 201262Aug 13, 201411Apr 24, 201573
-54.55%Oct 19, 20111Oct 19, 20111Feb 8, 20122
-50.98%Apr 12, 20112May 9, 20114Oct 6, 20116

AYTUVolatility Chart

Current Aytu BioPharma, Inc. volatility is 61.14%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%100.00%200.00%300.00%400.00%AprilMayJuneJulyAugustSeptember
61.14%
30.01%
AYTU (Aytu BioPharma, Inc.)
Benchmark (^GSPC)